Janney Montgomery Scott LLC lessened its stake in Sanofi (NASDAQ:SNY – Free Report) by 0.3% in the third quarter, according ...

Shares of Sanofi (NASDAQ:SNY – Get Free Report) have received a consensus rating of “Moderate Buy” from the four brokerages that are currently covering the stock, Marketbeat reports. Two analysts have ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

PARIS, Oct 17 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said ... All candidates had the same opportunity to submit their best offers within the process deadline, the company ...

SHANGHAI, Nov. 7 (Xinhua) -- In the vast and intricately designed National Exhibition and Convention Center (Shanghai), where ...

SHANGHAI, Nov. 7 (Xinhua) -- In the vast and intricately designed National Exhibition and Convention Center (Shanghai), where ...

Sanofi SNY reported ... This French pharma giant’s top-line growth of almost 16% was driven by higher sales of Dupixent and contributions from new products like Altuviiio, Rezurock and ...

Sanofi and CD&R enter exclusive negotiations to transfer a 50 ... Headquartered in France, Opella employs over 11,000 talented and passionate people, operates in 100 countries with 13 best-in-class ...

This eases the user's understanding of the market thoroughly, while also gaining knowledge about Anxiety Disorder Treatment market opportunities and the dominant players Pfizer Inc, Merck KGaA, Sanofi ...

Chronic Lower Back Pain (CLBP) market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis ...

Multinational pharmaceutical and medical equipment companies will bring a variety of innovative medical solutions that ...